These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1576620)

  • 1. Cost-analysis of imipenem-cilastatin monotherapy compared with clindamycin+aminoglycoside combination therapy for treatment of serious lower respiratory, intra-abdominal, gynecologic, and urinary tract infections.
    Kreter B
    Clin Ther; 1992; 14(1):110-21. PubMed ID: 1576620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of two comparative antibiotic regimens in the treatment of serious intra-abdominal infections: results of a multicenter study.
    Eckhauser FE; Knol JA; Raper SE; Mulholland MW; Helzerman P
    Clin Ther; 1992; 14(1):97-109. PubMed ID: 1576632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparative trial of imipenem/cilastatin versus aminoglycoside plus amoxycillin plus clindamycin in the treatment of severe intra- and post-operative infections.
    Cakmakci M; Stern A; Schilling J; Christen D; Roggo A; Geroulanos S
    Drugs Exp Clin Res; 1993; 19(5):223-7. PubMed ID: 8174495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postpartum endometritis: efficacy and tolerability of two antibiotic regimens.
    Gonik B
    Clin Ther; 1992; 14(1):83-9. PubMed ID: 1576630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of imipenem-cilastatin versus clindamycin+gentamicin for serious pelvic infections.
    Larsen JW; Gabel-Hughes K; Kreter B
    Clin Ther; 1992; 14(1):90-6. PubMed ID: 1576631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imipenem/cilastatin versus aminoglycoside plus amoxicillin plus clindamycin in the treatment of serious postoperative infections.
    Christen D; Buchmann P; Geroulanos S
    Scand J Infect Dis Suppl; 1987; 52():11-4. PubMed ID: 3331039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of the cost-/effectiveness relationship of initial therapy with imipenem/cilastatin in nosocomial pneumonia. Group study].
    Rodloff AC; Laubenthal HJ; Bastian A; Bestehorn K; Büchele G; Gaus W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Apr; 31(3):172-80. PubMed ID: 8672620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipenem-cilastatin.
    Dinsmoor MJ
    Obstet Gynecol Clin North Am; 1992 Sep; 19(3):475-82. PubMed ID: 1436925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evidence-based medicine, health costs and treatment of intra-abdominal infection].
    Badía X; Brosa M; Tellado JM
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():86-94. PubMed ID: 10605193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, controlled clinical trial on meropenem versus imipenem/cilastatin for the treatment of bacterial infections.
    Hou F; Li J; Wu G; Zheng B; Chen Y; Gu J; Wang H; Huo L; Xue X; Jia C; Yin Y; Tian X; Ren S
    Chin Med J (Engl); 2002 Dec; 115(12):1849-54. PubMed ID: 12622937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost efficacy of tazobactam/piperacillin versus imipenem/cilastatin in the treatment of intra-abdominal infection.
    Dietrich ES; Schubert B; Ebner W; Daschner F
    Pharmacoeconomics; 2001 Jan; 19(1):79-94. PubMed ID: 11252548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections.
    Garbino J; Villiger P; Caviezel A; Matulionyte R; Uckay I; Morel P; Lew D
    Infection; 2007 Jun; 35(3):161-6. PubMed ID: 17565457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group.
    Colardyn F; Faulkner KL
    J Antimicrob Chemother; 1996 Sep; 38(3):523-37. PubMed ID: 8889726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of imipenem/cilastatin with the combination of cefuroxime and metronidazole in the treatment of intra-abdominal infections.
    Angerås MH; Darle N; Hamnström K; Ekelund M; Engström L; Takala J; Viste A; Holme JB
    Scand J Infect Dis; 1996; 28(5):513-8. PubMed ID: 8953684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contribution of imipenem/cilastatin in the treatment of peritonitis: a comparative economic analysis in the case of France].
    Levy E; Levy P
    J Chir (Paris); 1993 Apr; 130(4):200-9. PubMed ID: 8345014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.
    Caldwell JW; Singh S; Johnson RH
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():129-34. PubMed ID: 10225583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of imipenem-cilastatin versus ceftazidime plus tobramycin as empiric therapy of presumed bacterial infection in neutropenic cancer patients.
    Miller JA; Butler T; Beveridge RA; Kales AN; Binder RA; Smith LJ; Ueno WM; Milkovich G; Goldwater S; Marion A
    Clin Ther; 1993; 15(3):486-99. PubMed ID: 8364941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic equivalence of generic imipenem/cilastatin for therapy of infections at Siriraj Hospital.
    Piyasirisilp S; Premprawat W; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S117-25. PubMed ID: 20364566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients.
    McKinnon PS; Paladino JA; Grayson ML; Gibbons GW; Karchmer AW
    Clin Infect Dis; 1997 Jan; 24(1):57-63. PubMed ID: 8994756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
    Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
    Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.